This trial is testing a new immunotherapy called ELI-002 7P. It is for people with pancreatic or colorectal cancer that has a specific genetic change (KRAS or NRAS mutation) and who have already had surgery and chemotherapy. The goal is to see if this treatment can safely help th…
Phase: PHASE1, PHASE2 • Sponsor: Elicio Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC